Sernova Biotherapeutics

(TSX) SVA

Current PriceCA$0.16

Market CapCA$53.90M

Since IPO (2000)-96%

5 Year-90%

1 Year-9%

1 Month-11%

Sernova Biotherapeutics Financials at a Glance

Market Cap

CA$53.90M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$12.38M

EPS (TTM)

-CA$0.04

P/E Ratio

-4.14

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$0.16

Volume

113,954

Open

CA$0.16

Price

CA$0.16

Volume

113,954

Open

CA$0.16

Previous Close

CA$0.16

Daily Range

CA$0.15 - CA$0.16

52-Week Range

CA$0.12 - CA$0.21

Estimated Earnings Date

Jun 11, 2026

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$0.16

Volume

113,954

Open

CA$0.16

Previous Close

CA$0.16

Daily Range

CA$0.15 - CA$0.16

52-Week Range

CA$0.12 - CA$0.21

Estimated Earnings Date

Jun 11, 2026

SVA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sernova Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jonathan M. N. Rigby, MBA

Website

www.sernova.com

Headquarters

London, ON N6G 4X8, GB

SVA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

50%

Return on Assets

-12%

Earnings Yield

-24.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$53.90M

Shares Outstanding

347.73M

Volume

113.95K

Avg. Volume

121.88K

Financials (TTM)

Gross Profit

-CA$342.59K

Operating Income

-CA$15.12M

EBITDA

-CA$14.74M

Operating Cash Flow

-CA$10.91M

Capital Expenditure

-CA$3.00

Free Cash Flow

-CA$10.91M

Cash & ST Invst.

CA$265.00K

Total Debt

CA$17.28M

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$4.43K

+90.7%

Gross Margin

0.00%

N/A

Market Cap

CA$53.90M

N/A

Market Cap/Employee

CA$3.17M

N/A

Employees

N/A

Net Income

-CA$2.33M

+59.0%

EBITDA

-CA$2.11M

+61.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-CA$16.97M

-2667.4%

Accounts Receivable

CA$125.59K

-66.4%

Inventory

CA$0.00

N/A

Long Term Debt

CA$1.08M

+145.2%

Short Term Debt

CA$16.47M

+15407.5%

Return on Assets

-12.23%

N/A

Return on Invested Capital

50.18%

N/A

Free Cash Flow

-CA$1.05M

+78.3%

Operating Cash Flow

-CA$1.05M

+78.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

COV.VCovalon Technologies Ltd.

COV.VCovalon Technologies Ltd.CA$2.15+9.14%

MIR.VMedMira Inc.

MIR.VMedMira Inc.CA$0.06+0.00%

MBX.TOMicrobix Biosystems Inc.

MBX.TOMicrobix Biosystems Inc.CA$0.27+0.00%

RVX.TOResverlogix Corp.

RVX.TOResverlogix Corp.CA$0.10-5.00%

BCT.TOBriaCell Therapeutics Corp.

BCT.TOBriaCell Therapeutics Corp.CA$4.49-1.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

STISolidion Technology

STISolidion Technology$22.71+3.51%

NOKNokia

NOKNokia$16.62-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.76+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.64-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$85.22-0.02%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$17.89+0.06%

INTCIntel

INTCIntel$111.78-0.01%

Questions About SVA

What is the current price of Sernova Biotherapeutics?

Sernova Biotherapeutics is trading at CA$0.16 per share.

What is the 52-week range for Sernova Biotherapeutics?

Over the past 52 weeks, Sernova Biotherapeutics has traded between CA$0.12 and CA$0.21.

How much debt does Sernova Biotherapeutics have?

As of the most recent reporting period, Sernova Biotherapeutics reported total debt of CA$17.55M.

How much cash does Sernova Biotherapeutics have on hand?

Sernova Biotherapeutics reported CA$576.22K in cash and cash equivalents in its most recent financial results.

What is Sernova Biotherapeutics’s dividend yield?

Sernova Biotherapeutics does not currently have a dividend yield.

Sernova Biotherapeutics

Sernova Biotherapeutics Financials at a Glance

SVA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sernova Biotherapeutics

SVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SVA

What is the current price of Sernova Biotherapeutics?

What is the 52-week range for Sernova Biotherapeutics?

How much debt does Sernova Biotherapeutics have?

How much cash does Sernova Biotherapeutics have on hand?

What is Sernova Biotherapeutics’s dividend yield?

Premium Investing Services